Dimerix Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply![Get A$10 trading credit to start you off](/images/content-cards/reward_content_card.png)
About DXB
Dimerix Limited (DXB) is a clinical-stage biopharmaceutical company working to improve the lives of patients with inflammatory diseases, including both kidney and respiratory diseases. Dimerix is currently focused on developing its proprietary Phase 3 product candidate DMX-200, for Focal Segmental Glomerulosclerosis (FSGS) kidney disease, and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD).
Buy Australian shares starting with DXB. Invest today with a CHESS-sponsored investing platform!
Sector
Health Care
CEO
-
Industry
Biotechnology
Website
dimerix.com
$256M
-11.08
-
$0.49
$0.47
$0.47
$0.67
$0.06
Announcements
Ready to start your investing journey with Stake?
Open an accountDXB FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in DXB
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DXB
on Stake
Buy DXB from AU$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
![Canstar award phone](/_next/image?url=%2Fimages%2Fstocks%2Fsidebar_phone_4x.png&w=3840&q=75)